Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-56,718
Closed -$4.54M 75
2019
Q2
$4.54M Hold
56,718
0.33% 50
2019
Q1
$4.5M Sell
56,718
-59,379
-51% -$4.44M 0.33% 53
2018
Q4
$8.46M Sell
116,097
-709,151
-86% -$50.1M 0.7% 43
2018
Q3
$55.9M Sell
825,248
-115,287
-12% -$7.34M 4.33% 4
2018
Q2
$54.5M Buy
940,535
+151,810
+19% +$8.56M 4.24% 3
2018
Q1
$41M Buy
788,725
+52,526
+7% +$2.84M 3.51% 5
2017
Q4
$39.5M Buy
736,199
+139,373
+23% +$7.73M 3.7% 2
2017
Q3
$36.5M Buy
596,826
+87,173
+17% +$5.29M 3.67% 3
2017
Q2
$31.2M Sell
509,653
-82,341
-14% -$5.01M 3.13% 6
2017
Q1
$35.9M Buy
591,994
+227,091
+62% +$13.8M 4.08% 2
2016
Q4
$20.5M Buy
364,903
+30,465
+9% +$1.78M 2.79% 8
2016
Q3
$19.9M Buy
334,438
+1,887
+0.6% +$110K 2.79% 5
2016
Q2
$18.3M Sell
332,551
-211,675
-39% -$11.3M 3.17% 5
2016
Q1
$27.5M Buy
544,226
+164,106
+43% +$8.04M 4.96% 2
2015
Q4
$19.2M Buy
380,120
+199,529
+110% +$10.1M 4.32% 2
2015
Q3
$8.51M Buy
+180,591
New +$9.59M 2.49% 16

Other funds holding MRK

LGT Capital Partners's MRK Position: Q3 2019 in Review

LGT Capital Partners sold out of Merck (MRK) in Q3 2019, closing a stake of 56,718 shares — an estimated $4.54M sold.

LGT Capital Partners first reported a position in MRK in Q3 2015 and held it in 16 quarters. The position peaked at $55.9M in Q3 2018. 2,306 funds tracked by Wall St. Rank hold MRK as of Q3 2019.

  • LGT Capital Partners reported no remaining Merck position as of Q3 2019 after selling out during the quarter.
  • LGT Capital Partners sold 56,718 Merck shares in Q3 2019, an estimated $4.54M.
  • LGT Capital Partners first reported a position in Merck in Q3 2015 and held it in 16 quarters.
  • LGT Capital Partners's Merck position peaked at $55.9M in Q3 2018.
  • 2,306 funds tracked by Wall St. Rank held Merck as of Q3 2019.

Based on LGT Capital Partners's 13F filing for Q3 2019, filed 7 Oct 2019.